SAJDVD: VOLUME 6, ISSUE 2, JUNE 2009
- Title: The need for a diabetes
charter in South Africa : editorial
Authors: Mahomed, F.A.
From: South African Journal of Diabetes and Vascular Disease, Vol 6, Issue 2, Jun
Published: 2009
Pages: 47
Full text: Click here to order
Full text: Click here to read online (Login Required)
Abstract: Diabetes is increasingly becoming a major problem in South Africa. In rural areas, overall age-adjusted prevalence of diabetes is 3.9%, but in other subgroups, for example in South Africans of Indian origin, up to 16.2% of the population may have diabetes.
- Title: Patient's constitutional
rights regarding the management of chronic
diseases in South Africa : editorial
Authors: Klinck, Elsabe
From: South African Journal of Diabetes and Vascular Disease, Vol 6, Issue 2, Jun
Published: 2009
Pages: 49-50
Full text: Click here to order
Full text: Click here to read online (Login Required)
Abstract: This article briefly examined some of the constitutional issues relating to the right of access to healthcare, and the duties placed not only on policymakers and programme managers, but also on medical practitioners to ensure compliance with the criteria set by the Constitution.
- Title: A diabetes strategy for
(South) Africa : regaining momentum : editorial
Authors: Mollentze, W.F.
From: South African Journal of Diabetes and Vascular Disease, Vol 6, Issue 2, Jun
Published: 2009
Pages: 50-51
Full text: Click here to order
Full text: Click here to read online (Login Required)
Abstract: The historic 19th meeting of the International Diabetes Federation (IDF) in Cape Town in December 2006 put diabetes mellitus in Africa, and South Africa in particular, under the spotlight. This meeting will be remembered for the launch of the African Diabetes Declaration, which was also signed by the South African Minister of Health. The purpose of the declaration is to raise community and political awareness about diabetes and to improve diabetes care by working through a coalition of individuals, communities, corporations and governments.
- Title: Treatment of hypertension in
diabetic patients : the ASH position paper
provides valuable insights : review
Authors: Aalbers, Julia
From: South African Journal of Diabetes and Vascular Disease, Vol 6, Issue 2, Jun
Published: 2009
Pages: 52
Full text: Click here to order
Full text: Click here to read online (Login Required)
Abstract: The American Society for Hypertension (ASH) has published a position paper (2008) with a very useful algorithm for treating hypertension in diabetic patients (figure 1). Incorporating many of the most recent trials until July 2008, the position paper notes that while the basic approach to achieving blood pressure control in persons with diabetes has not changed appreciably from the JNC VII guidelines, some important new considerations have emerged.
- Title: Triglycerides : making sense
of the forgotten lipid fraction : review
Authors: Morrell, Jonathan
From: South African Journal of Diabetes and Vascular Disease, Vol 6, Issue 2, Jun
Published: 2009
Pages: 55-58
Full text: Click here to order
Full text: Click here to read online (Login Required)
Abstract: The importance of lowering total and LDL cholesterol (LDL-C) in the prevention of cardiovascular disease (CVD) is so firmly established that it has, in only a short time, become part of everyday practice for all primary care health professionals. Lipids, of course, come in multiple forms, which include fatty acids, the different forms of cholesterol and triglycerides. Most practitioners have only a sketchy idea of what triglycerides are, what they do and how important they are. Few understand the intricacies of measurement, diagnosis and interpretation, and when - and how - to manage them. The story is complex and involves difficult biochemical and metabolic concepts, so we should begin at the beginning.
- Title: Taking aspirin for the
prevention of cardiovascular disease : patient
information leaflet
From: South African Journal of Diabetes and Vascular Disease, Vol 6, Issue 2, Jun
Published: 2009
Pages: 59
Full text: Click here to order
Full text: Click here to read online (Login Required)
Abstract: Taking aspirin for the prevention of cardiovascular disease
- Title: Diabetes management made
easier : insulin delivery devices : hands on
Authors: Kok, J.A.
From: South African Journal of Diabetes and Vascular Disease, Vol 6, Issue 2, Jun
Published: 2009
Pages: 61-62
Full text: Click here to order
Full text: Click here to read online (Login Required)
Abstract: South Africa is one of the major consumers of insulin pen devices in the world. For those patients who need to use multiple injections per day, making insulin injections easier and more comfortable assists them in complying with a treatment plan. This article discusses the delivery devices available and some of the advantages of each.
- Title: Overcoming the challenges of
a resource-poor environment to deliver quality
diabetes care in a public-sector clinic :
diabetes personality
Authors: Tupy, Dana
From: South African Journal of Diabetes and Vascular Disease, Vol 6, Issue 2, Jun
Published: 2009
Pages: 64-65
Full text: Click here to order
Full text: Click here to read online (Login Required)
Abstract: To manage patients with a chronic disease like diabetes, it is essential first and foremost to earn their trust. Once you achieve that, understanding them and knowing what's on their minds, you will be able to treat them properly.
- Title: South African Cookbook for
Diabetes and Insulin Resistance 1, Hilda Lategan
: book review
From: South African Journal of Diabetes and Vascular Disease, Vol 6, Issue 2, Jun
Published: 2009
Pages: 65
Full text: Click here to order
Full text: Click here to read online (Login Required)
Abstract: The South African Cookbook for Diabetes and Insulin Resistance 1 promotes good blood sugar control and optimal health.
- Title: Management of the diabetic
patient in a resource-constrained environment :
roundtable discussion
Authors: Mollentze, W.F.
From: South African Journal of Diabetes and Vascular Disease, Vol 6, Issue 2, Jun
Published: 2009
Pages: 66-73
Full text: Click here to order
Full text: Click here to read online (Login Required)
Abstract: A century ago diabetes was virtually unknown in Africa. Currently 10 million people are living with this disease in Africa and the number is predicted to double by 2025. Type 2 diabetes accounts for 85 to 95% of all cases in the region. The main factors responsible for the rapid increase in the prevalence of diabetes in sub-Saharan Africa are an aging population, unhealthy diet, overweight and obesity, and a sedentary lifestyle, closely related to rapid urbanisation of the population in the region.
- Title: News from the 2009 SEMDSA
Congress : drug trends
From: South African Journal of Diabetes and Vascular Disease, Vol 6, Issue 2, Jun
Published: 2009
Pages: 75
Full text: Click here to order
Full text: Click here to read online (Login Required)
Abstract: The major development at the Society of Endocrinology, Metabolism and Diabetes of South Africa (SEMDSA) congress was the publication of the new South African guidelines for the management of type 2 diabetes.
- Title: Report from Sanofi Aventis
diabetes cardio-thrombosis meeting : drug trends
From: South African Journal of Diabetes and Vascular Disease, Vol 6, Issue 2, Jun
Published: 2009
Pages: 76, 78-79
Full text: Click here to order
Full text: Click here to read online (Login Required)
Abstract: Modern strategies to optimise blood glucose in type 2 diabetes.
Differences in insulin preparations / models : do they matter?
- Title: Novo Nordisk Diabetes Update
Symposium : April 2009 : drug trends
From: South African Journal of Diabetes and Vascular Disease, Vol 6, Issue 2, Jun
Published: 2009
Pages: 79, 80-82
Full text: Click here to order
Full text: Click here to read online (Login Required)
Abstract: This well-attended symposium set the scene for the annual SEMDSA meeting, which followed at the Wanderers Club, Johannesburg. This report summarises the major points of the interesting reviews from both local and overseas experts.
- Title: Incretin therapy: a new
treatment modality in the fight against the
worldwide diabetes epidemic : drug trends
From: South African Journal of Diabetes and Vascular Disease, Vol 6, Issue 2, Jun
Published: 2009
Pages: 83-84
Full text: Click here to order
Full text: Click here to read online (Login Required)
Abstract: The launch in South Africa of the first incretin mimetic, exenatide (Byetta, Lilly), offers local clinicians a first-in-a-class new option for treating type 2 diabetic patients who are not yet insulin dependent.
- Title: Testosterone : the missing
link in the treatment of type 2 diabetes : drug
trends
From: South African Journal of Diabetes and Vascular Disease, Vol 6, Issue 2, Jun
Published: 2009
Pages: 86
Full text: Click here to order
Full text: Click here to read online (Login Required)
Abstract: Treating male diabetic patients with testosterone corrects hypogonadal symptoms and leads to reduced waist circumference, increased muscle mass and insulin sensitivity, and lower lipid and blood pressure levels.
- Title: Diabetes news
From: South African Journal of Diabetes and Vascular Disease, Vol 6, Issue 2, Jun
Published: 2009
Pages: 88
Full text: Click here to order
Full text: Click here to read online (Login Required)
Abstract: SEMDSA News
Donation to Life for a Child programme
LATEST EDITORS' CHOICE
Interesting
features, including:
- Cardiometabolic risk factors in male long-distance bus drivers
- Endothelial dysfunction in patients with hyperlipidaemia
- Hypertension in newly diagnosed diabetic patients in Uganda
- Microalbuminuria and left ventricular dysfunction in type 2 diabetes
- SGLT-2 inhibitors in type 2 diabetes: protecting kidney and heart
- African roadmap: 25% hypertension control in Africa by 2025
RELIABLE EXPERT INFORMATION
The SAJDVD’s main focus is
providing new and relevant information for doctors,
nurses and allied professionals involved in caring
for the diabetes patient.
But as we are part of the larger Diabetes team, we would like to reach out to all patients with relevant information. So here it is!
But as we are part of the larger Diabetes team, we would like to reach out to all patients with relevant information. So here it is!